This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Li Zhu in Cancer Treatment
Introduction
Li Zhu is a notable inventor based in Princeton, NJ, who has made significant strides in the field of cancer treatment. His work focuses on developing innovative methods that combine monoclonal antibodies with specific compounds to enhance therapeutic efficacy.
Latest Patents
Li Zhu holds a patent for "Compositions and methods of treating cancer." This patent outlines methods for treating cancer in subjects using a combination of a monoclonal antibody and (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide, or a salt thereof. This innovative approach aims to improve treatment outcomes for cancer patients.
Career Highlights
Li Zhu is currently employed at Bristol-Myers Squibb Company, a leading biopharmaceutical firm known for its commitment to discovering and developing innovative medicines. His work at the company has positioned him as a key contributor to advancements in cancer therapies.
Collaborations
Li Zhu collaborates with talented professionals in his field, including Paul Andrew Basciano and Justine Kamilah Walker. Their combined expertise fosters a collaborative environment that enhances the development of groundbreaking treatments.
Conclusion
Li Zhu's contributions to cancer treatment through his innovative patent and work at Bristol-Myers Squibb Company highlight the importance of research and collaboration in the fight against cancer. His efforts continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile